ENDOMETRIAL CANCER, ENDOMETRIAL NEOPLASM

Clinical trials for ENDOMETRIAL CANCER, ENDOMETRIAL NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL CANCER, ENDOMETRIAL NEOPLASM trials appear

Sign up with your email to follow new studies for ENDOMETRIAL CANCER, ENDOMETRIAL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New cancer drug enters human testing for Hard-to-Treat tumors

Disease control Ongoing

This is the first human trial testing a new cancer drug called GEN1047 in people with advanced solid tumors, including breast, ovarian, endometrial, and a type of lung cancer. The main goals are to find a safe dose and see if the drug helps shrink tumors. All 179 participants wil…

Matched conditions: ENDOMETRIAL CANCER, ENDOMETRIAL NEOPLASM

Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

ENDOMETRIAL CANCER, ENDOMETRIAL NEOPLASM

Get alerted when new ENDOMETRIAL CANCER, ENDOMETRIAL NEOPLASM trials appear

New cancer drug enters human testing for Hard-to-Treat tumors